Orgenesis Inc. Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Comprehensive Loss (Income)

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Customer D (United States)
Nonrelated Party
Related Party
Total customer D (United States)
Revenues from related party
Total revenues
Cost of revenues
Gross loss
Cost of development services and research and development expenses
Amortization of intangible assets
Change in Contingent consideration
Selling, general and administrative expenses included credit losses of $2,724 for the year ended December 31, 2024 and ($24,367 for the year ended December 31, 2023)
Share in net loss of associated companies
Impairment of investment
Impairment charges
Impairment charges of other investment
Impairment of long-lived assets
Operating loss
Loss (profit) from deconsolidation of OBI, Korea, Belgium, Services and Octomera (see note 3 and note 20)
Other income, net
Loss from extinguishment in connection with loans
Credit loss on convertible loan receivable
Financial expenses, net
Inducement expense on conversion of convertible loans
Loss before income taxes
Tax expense
Net loss from continuing operation
Net loss income from Discontinued Operation, Net of Tax
Other Comprehensive (income) loss – Translation adjustment
Release of translation adjustment due to sale of subsidiary
Comprehensive loss (income)
Comprehensive loss attributed to non-controlling interests (including redeemable)
Comprehensive loss attributed to non-controlling interests (including redeemable) from discontinued operations
Comprehensive loss attributed to non-controlling interests
Comprehensive loss attributed to non-controlling interests from discontinued operations
Net income from discontinued operations, net of tax
Net loss
Net loss attributable to non-controlling interests from discontinued operations
Net (loss) income attributable to non-controlling interests
Net loss attributable to Orgenesis Inc.
Basic and diluted from continuing operation
Basic and diluted from discontinued operation
Basic
Diluted
Weighted average number of shares used in computation of Basic and Diluted loss per share:
Basic and diluted
Basic
Diluted

Comprehensive loss:
Net loss from Continuing Operation
Other Comprehensive loss – Translation adjustment
Release of translation adjustment due to deconsolidation of Orgenesis Korea and the Belgian Subsidiary in 2024 (Octomera in 2023)
Comprehensive loss
Comprehensive (loss) income attributed to non-controlling interests
Comprehensive loss attributed to Orgenesis Inc.

Comments